No Data
No Data
Blue sail medical: The leader makes another breakthrough, partnering with wanhua chemical group to launch a new type of gloves, redividing the market.
Blue Sail Medical (002382.SZ): Currently, the polyurethane gloves are being produced on the modified latex gloves production line, achieving small-scale production.
Gelonghui November 4th, blue sail medical (002382.SZ) stated on the investor interaction platform that since 2019, the company has been collaborating with Wanhua Chemical Group to explore the application of polyurethane in the field of gloves. After more than five years of close cooperation and unremitting efforts, the two teams successfully launched a new polyurethane glove product with outstanding performance in August this year. Currently, the polyurethane gloves are produced on modified latex glove production lines, achieving small-scale production, and the products are sold both domestically and internationally. Due to the lack of obvious shortcomings in polyurethane gloves and a qualitative leap in puncture resistance, high elasticity, allergen resistance, etc., they have received unanimous praise from customers. Following this.
Blue Sail Healthcare: Report for the third quarter of 2024
blue sail medical (002382.SZ) reported a net loss of 0.22 billion yuan in the first three quarters.
Gelonghui October 29th Blue Sail Medical (002382.SZ) released the third quarter report for 2024, achieving a revenue of 4.654 billion yuan in the first three quarters, a year-on-year increase of 29.85%; a net loss of 0.22 billion yuan. Among them, in the third quarter, revenue reached 1.649 billion yuan, a year-on-year increase of 24.68%; a net loss of 59.6061 million yuan.
Blue Sail Medical (002382.SZ) released its performance for the first three quarters, with a net loss of 0.22 billion yuan.
Blue Sail Medical (002382.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
Strong Week for Blue Sail MedicalLtd (SZSE:002382) Shareholders Doesn't Alleviate Pain of Three-year Loss
No Data
No Data